TrialNature communications2025
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations.
Tianshi Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it